Table 2

Prehospital HCRU in patients with STEMI and NSTE-ACS with or without a history of CVD

STEMINSTE-ACSOverall p value for STEMI vs NSTE-ACS
Resource use itemHistory of CVD (n=1042)No history of CVD (n=3857)All (n=4899)p Value for CVD vs no CVDHistory of CVD (n=2672)No history of CVD (n=2904)All (n=5576)p Value for CVD vs no CVD
ECG*444 (44.7)1717 (44.5)2161 (44.1)0.91973 (36.4)1058 (36.4)2031 (36.4)0.99<0.0001
Any prehospital CV medication261 (25.0)1043 (27.0)1304 (26.6)0.20376 (14.1)469 (16.2)845 (15.2)0.03<0.0001
 Any fibrinolytic17 (1.6)90 (2.3)107 (2.2)0.172 (0.1)3 (0.1)5 (0.1)0.72<0.0001
 Any antiplatelet agent256 (24.6)1026 (26.6)1282 (26.2)0.19358 (13.4)465 (16.0)823 (14.8)0.01<0.0001
 Any anticoagulant131 (12.6)571 (14.8)702 (14.3)0.07113 (4.2)139 (4.8)252 (4.5)0.32<0.0001
Ambulance transfer, n (%)†352 (33.7)1519 (39.4)1871 (38.2)0.001735 (27.5)1016 (35.0)1751 (31.4)<0.0001<0.0001
 Duration, minutes; mean (SD)72.0 (86.8)64.6 (73.8)66.0 (76.4)0.1463.5 (85.2)65.4 (75.5)64.6 (79.7)0.630.59
  Median (range)47.5 (8–950)45 (1–960)45 (1–960)40 (5–900)45 (5–999)45 (5–999)
  • Values are n (%) unless otherwise indicated.

  • *ECG data were unavailable for 254 patients.

  • †Transport between hospitals, not transport to initial hospital.

  • CV, cardiovascular; CVD, CV disease; HCRU, healthcare resource use; NSTE-ACS, non-ST-segment elevation acute coronary syndrome; STEMI, ST-segment elevation myocardial infarction.